Skip to main content

Disclaimer: This is not legal advice. Legislation and case law change. Always consult a qualified solicitor for your specific situation.

UK Law Reference
All Statutory Instruments
UK Statutory Instrument
UKSI 2026/1184
UK-wide
final

The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 3) Regulations 2026

The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 3) Regulations 2026

Independent editorial summary — not the official statute text. Read the official version on legislation.gov.uk.

Type: UK Statutory Instrument

Year: 2026

Number: 1184

Made: 2026-11-11

Coming into force: 2026-12-10

Last ingested: 2026-11-16 from legislation.gov.uk.

Read the full text on legislation.gov.uk

Explanatory note

Reproduced verbatim from the instrument as published on legislation.gov.uk (Crown Copyright, Open Government Licence v3.0). The note is prepared by the responsible government department and is not part of the instrument itself.

These Regulations make amendments to the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (“ the PLPS Regulations ”). The PLPS Regulations govern arrangements, in England, for the provision of pharmaceutical services and local pharmaceutical services under Part 7 of the National Heath Service Act 2006.

The terms of service of community pharmacies providing pharmaceutical and local pharmaceutical services are set out in Schedules 4 and 7 of the PLPS Regulations. Both sets of terms of service are amended to take account of changes relating to the supervision of the supply of pharmacy and prescription only medicines at or from pharmacies that were included in regulations 220A and 220B of the Human Medicines Regulations 2012 ( S.I. 2012/1916 ) (HMRs), inserted by the Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 ( S.I. 2025/1249 ). The principles set out in those provisions of the HMRs will also apply to the authorisation and supervision of the supply of other NHS prescription items.

Previously, supplies of NHS prescription items had to be by or under the direct supervision of a pharmacist. Going forward there will be three options: supply by or under the supervision of a pharmacist; supply by or under the supervision of a pharmacy technician, where that has been authorised by a pharmacist; and supply of dispensed items that a pharmacist who is to be absent has authorised another member of the pharmacy staff to carry out (known as supply of “checked and bagged” items). Generally, supplies of NHS prescription items will only be possible where a pharmacist is at the pharmacy, but an exception is made for checked and bagged items, which can be supplied when there is no pharmacist at the pharmacy because of a short rest break -– or because the pharmacy is open outside of its NHS opening hours but the responsible pharmacist signed in at the pharmacy is nevertheless permitted to be absent. Other provisions relating to final supply of prescription items are also updated to take account of the new arrangements enabling the authorisation of pharmacy technicians to carry out or supervise such supplies.

A full impact assessment has not been prepared for this instrument as no, or no significant, impact on the public sector is foreseen, and only a limited impact on the private sector, below the threshold for producing a full impact assessment.

Other UKSIs from 2026